Plant ID: NPO25122
Plant Latin Name: Conium maculatum
Taxonomy Genus: Conium
Taxonomy Family: Apiaceae
NCBI TaxonomyDB:
13447
Plant-of-the-World-Online:
n.a.
Analgesic; Antirheumatic; Antispasmodic; Cancer; Emetic; Galactofuge; Homeopathy; Sedative
Turkey; Italy; Lebanon; Finland; India; China; Chile; Argentina; Spain
TSHR; | |
PTPN1; | |
TDP1; MTOR; GFER; HSD17B10; ALDH1A1; | |
CA2; CA1; CA12; CA9; CA7; CA3; CA14; CA5B; CA5A; CA6; | |
CTSD; | |
CASP1; CASP7; | |
MMP9; MMP1; MMP2; | |
HIF1A; TP53; NFKB1; | |
HTT; LMNA; THPO; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Aspartic protease | CTSD | Cathepsin D | P07339 | CHEMBL2581 |
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | MTOR | Serine/threonine-protein kinase mTOR | P42345 | CHEMBL2842 |
Enzyme_unclassified | GFER | FAD-linked sulfhydryl oxidase ALR | P55789 | CHEMBL1741189 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Metallo protease | MMP9 | Matrix metalloproteinase 9 | P14780 | CHEMBL321 |
Metallo protease | MMP1 | Matrix metalloproteinase-1 | P03956 | CHEMBL332 |
Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.906E-11 | 5.187E-08 | CA1, CA12, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9, MMP1, MMP2, MMP9, PTPN1, TP53 |
BP | Unclassified; | GO:0044259; multicellular organismal macromolecule metabolic process | 3.346E-07 | 5.605E-04 | CTSD, HIF1A, MMP1, MMP2, MMP9 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.391E-25 | 3.028E-21 | CA1, CA12, CA14, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
BP | Unclassified; | GO:0044236; multicellular organism metabolic process | 9.504E-07 | 1.380E-03 | CTSD, HIF1A, MMP1, MMP2, MMP9 |
BP | GO:0008152; metabolic process | GO:0030574; collagen catabolic process | 4.440E-06 | 5.742E-03 | CTSD, MMP1, MMP2, MMP9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 8.482E-06 | 7.924E-03 | CA2, CA7 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.114E-19 | 1.212E-15 | CA1, CA12, CA14, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.421E-18 | 1.862E-14 | CA1, CA12, CA2, CA3, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 4.228E-05 | 2.368E-02 | CA1, CA2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 6.347E-25 | 7.235E-23 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA7, CA6, CA9, CA14 |
09160 Human Diseases | 09161 Cancers | hsa05219 | Bladder cancer | 5.956E-07 | 3.395E-05 | MMP1, MMP2, MMP9, TP53 |
09160 Human Diseases | 09161 Cancers | hsa05200 | Pathways in cancer | 3.151E-06 | 9.038E-05 | MMP1, MMP2, HIF1A, TP53, MMP9, NFKB1, MTOR |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 3.171E-06 | 9.038E-05 | CASP7, LMNA, TP53, CTSD, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 1.931E-05 | 4.404E-04 | MMP2, TP53, HIF1A, MMP9, MTOR |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 1.013E-04 | 1.924E-03 | CASP7, CASP1, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 1.824E-04 | 2.971E-03 | TP53, HIF1A, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 4.219E-04 | 5.345E-03 | TP53, NFKB1, MTOR |
09150 Organismal Systems | 09149 Aging | hsa04211 | Longevity regulating pathway - mammal | 4.953E-04 | 5.646E-03 | TP53, NFKB1, MTOR |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 2.549E-04 | 3.632E-03 | CASP7, CASP1, NFKB1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 6.468E-04 | 6.704E-03 | HIF1A, NFKB1, MTOR |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04668 | TNF signaling pathway | 7.832E-04 | 6.868E-03 | CASP7, MMP9, NFKB1 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04931 | Insulin resistance | 7.627E-04 | 6.868E-03 | PTPN1, NFKB1, MTOR |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 9.600E-04 | 7.427E-03 | TP53, HIF1A, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05206 | MicroRNAs in cancer | 1.389E-03 | 9.313E-03 | TP53, MMP9, NFKB1, MTOR |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 1.008E-03 | 7.427E-03 | TP53, CTSD, NFKB1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.042E-03 | 7.427E-03 | CYP1A2, CYP2C19 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
C00-D49: Neoplasms | Lung cancer | C33-C34 | MMP2; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Osteoarthritis | M15-M19, M47 | MMP2; |
L00-L99: Diseases of the skin and subcutaneous tissue | Acne vulgaris | L70.0 | MMP2; |
C00-D49: Neoplasms | Ovarian cancer | C56 | MMP2; |
C00-D49: Neoplasms | Pancreatic cancer | C25 | MMP2; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Non-small-cell lung cancer | NA | MMP2; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | MMP9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MMP9; MMP2; CA9; |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR; |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | MMP1; |
I00-I99: Diseases of the circulatory system | Stroke | I61-I63, I80-I82 | MMP9; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; MMP9; MMP2; CA9; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Arthritis | M00-M25 | MMP1; |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR; |
K00-K95: Diseases of the digestive system | Ulcerative colitis | K51 | MMP9; |
C00-D49: Neoplasms | Renal cell carcinoma | NA | MMP2; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic nephropathy | E11.21 | MMP1; |